[Effect of luliberin in the treatment of mental disorders in cerebral arteriosclerosis].
The article presents the results of investigation into hypothalamic-hypophyseal-adrenal system in cerebral atherosclerosis leading to mental disorders. A hypothesis was put forward assuming a major role of luliberins in the pathogenesis of these disorders. Reported are the data on practical application of luliberin in the therapy of mental disorders in cerebral atherosclerosis. Clinical observations and inferences were confirmed in biochemical studies.
Tikhomirov
S M
SM
Bakharev
V M
VM
D000281:Administration, Intranasal; D000368:Aged; D001921:Brain / Q000378:metabolism; D015140:Dementia, Vascular / Q000188:drug therapy* / Q000209:etiology; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage* / Q000172:deficiency; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications / Q000378:metabolism / Q000523:psychology*; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy* / Q000209:etiology; D009497:Neurotic Disorders / Q000188:drug therapy* / Q000209:etiology
D006728:Hormones; D007987:Gonadotropin-Releasing Hormone
Effekty liuliberina v lechenii psikhicheskikh narusheniĭ pri tserebral'nom ateroskleroze.